- HTG Molecular Diagnostics Inc HTGM shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
- ZAIS Group Holdings, Inc. ZAIS shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
- Global Brokerage Inc GLBR shares jumped 24.3 percent to $2.30.
- Regulus Therapeutics Inc RGLS shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
- Rocket Fuel Inc FUEL shares gained 15.6 percent to $5.19.
- Akoustis Technologies Inc AKTS rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
- TOP SHIPS Inc TOPS shares gained 12.6 percent to $1.25.
- Inventure Foods Inc SNAK jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
- CymaBay Therapeutics Inc CBAY surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
- Micron Technology, Inc. MU climbed 8.6 percent to $28.75 after the company reported better-than-expected earnings for its second quarter and issued a strong forecast for the third quarter.
- Sophiris Bio Inc SPHS jumped 7.4 percent to $2.77. Sophiris reported that the data from its Phase 2a study of topsalysin will be presented at the 32nd Annual European Association of Urology in London, UK.
- Eleven Biotherapeutics Inc EBIO gained 7.2 percent to $2.04 after the company posted a narrower-than-expected quarterly loss.
- Skechers USA Inc SKX rose 4.9 percent to $28.77. Cowen & Co. upgraded Skechers USA from Market Perform to Outperform.
- Under Armour Inc UAA shares gained 3.4 percent to $19.61. Jefferies upgraded Under Armour from Hold to Buy.
- Franks International NV FI gained 3 percent to $10.11. Jefferies upgraded Frank's International from Underperform to Hold.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in